Create account

Coverage dated September 29, 2026 to September 30, 2026

STAT+: Three biotech updates, including accusations of theft and and a new lobbying leader

Headline from STAT

Beam Therapeutics has filed a lawsuit alleging one of its former scientists stole intellectual property and used it to co-found a Chinese company that recently made a deal with prominent VC…

STAT's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

4 articles, oldest first.

  1. STAT

    STAT+: Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property (opens STAT)

    Published

    STAT's feed description

    The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to co-found a Chinese company that made a deal with VC firms.

  2. The Boston Globe

    Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property (opens The Boston Globe)

    Published

    The Boston Globe's feed description

    The Cambridge-based gene-editing company is alleging that one of its scientists stole intellectual property and used it to co-found a Chinese company that made a deal with VC firms.

  3. STAT

    STAT+: Pharmalittle: We’re reading about Beam suing over IP theft, a Trump rule on importing meds, and more (opens STAT)

    Published

    STAT's feed description

    Gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to co-found a Chinese company

  4. STAT

    STAT+: Three biotech updates, including accusations of theft and and a new lobbying leader (opens STAT)

    Published

    STAT's feed description

    Beam Therapeutics has filed a lawsuit alleging one of its former scientists stole intellectual property and used it to co-found a Chinese company that recently made a deal with prominent VC…

STAT+: Three biotech updates, including accusations of theft and and a new lobbying leader | Since Then